Clinical trial
Cholesterol-Lowering Effects of Policosanol
NCT00288483 · Drug Commission of the German Medical Association, Other · Terminated
Key facts
| NCT number | NCT00288483 |
|---|---|
| Title | Cholesterol-Lowering Effects of Policosanol |
| Official title | Placebo-Controlled, Randomised, Double-Blind, Multi-Centre Clinical Trial on Dose-Dependent Cholesterol-Lowering Effects of Policosanol in Patients With Hypercholesterolaemia With 10 to 80 Mg Policosanol for 12 Weeks |
| Lead sponsor | Drug Commission of the German Medical Association, Other |
| Collaborators | Madaus AG Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Combined Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Policosanol |
| Start date | Sep 1, 2000 |
| Completion | Jul 1, 2001 |
| First posted | Feb 8, 2006 |
| Last update posted | Jul 21, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: